Business · 1 sources covering this

Zydus Lifesciences Shares Tick Higher On USFDA Nod For Ascorbic Aid Injection

Zydus Lifesciences shares rose 1.67% from the day's low to Rs 1,117.80 after the company received final USFDA approval for Ascorbic Acid Injection USP.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Zydus Lifesciences Shares Tick Higher On USFDA Nod For Ascorbic Aid Injection
Zydus Lifesciences shares rose 1.67% from the day's low to Rs 1,117.80 after the company received final USFDA approval for Ascorbic Acid Injection USP.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/6aa46a5c4eefcd8a0c390aa9f62bbf3ed8d41e44"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Zydus Lifesciences Shares Tick Higher On USFDA Nod For Ascorbic Aid Injection"></iframe>

Zydus Lifesciences Shares Tick Higher On USFDA Nod For Ascorbic Aid Injection

How 1 sources are covering this

Zydus Lifesciences Shares Tick Higher On USFDA Nod For Ascorbic Aid Injection

More from Business

AI Chip Boom Drives Samsung Electronics' Record $80-Billion Shareholder Payout Plan

Wall Street Eyes Rebound: Easing Treasury Yields Among 3 Reasons Pushing S&P, Dow, Nasdaq Futures Higher

Best Crypto Week In Three Years: Bitcoin On Track For Massive Gains, Nears $80,000

Rupee settles on flat note, 3 paise higher at 95.71 against U.S. dollar

Reader

Trust & legal

Across the network